On-line continuous hemodiafiltration in sepsis.

Area of Science:

• Critical Care Medicine
• Nephrology
• Biomedical Engineering

Background:

• Continuous renal replacement therapy (CRRT) is vital for critical care patients with acute kidney injury (AKI).
• On-line hemodiafiltration (HDF) offers advantages in fluid management and solute removal.
• Sepsis-induced AKI presents significant challenges in critical care settings.

Purpose of the Study:

• To evaluate the safety and efficacy of on-line CHDF in critically ill patients with sepsis.
• To assess the impact of on-line CHDF on survival rates in septic shock patients with AKI.

Main Methods:

• On-line continuous hemodiafiltration (CHDF) was performed using bicarbonate-buffered dialysate and pyrogen-free fluids.
• A closed-loop balancing system automated the HDF process.
• The study included 123 septic shock patients over a 5-year period.

Main Results:

• On-line CHDF enabled virtually unlimited fluid volume exchange.
• The mean survival rate among the 123 septic shock patients was 54%.
• The system proved safe and effective in managing AKI in sepsis.

Conclusions:

• On-line CHDF is a safe and effective therapeutic option for acute kidney injury in sepsis.
• This technology supports continuous renal replacement therapy in critical care.
• The demonstrated survival rate highlights the potential clinical benefit of on-line CHDF in septic shock.